Nanoparticles Adjuvants in Allergology: New Challenges and Pitfalls

Area of Science:

• Immunology
• Nanotechnology
• Allergy Research

Background:

• Allergen immunotherapy (AIT) is the only curative treatment for allergic disorders, improving symptoms and preventing new sensitizations.
• Current AIT formulations have limitations regarding side effects, dosage, and administration time, impacting patient compliance.
• Nanotechnology offers potential advantages in drug delivery, including enhanced stability, bioavailability, and targeted delivery for biomedical applications.

Purpose of the Study:

• To review the synthesis of allergen/nanoparticle systems.
• To discuss the impact of these systems on the immune system.
• To assess immunomodulatory activity and immunotoxicity risks.

Main Methods:

• Literature review of allergen/nanoparticle system synthesis.
• Analysis of studies evaluating the impact of nanoparticles on the immune system.
• Discussion of immunomodulatory and immunotoxicological effects.

Main Results:

• Nanoparticles interact with the immune system, with outcomes dependent on physicochemical properties.
• Allergen/nanoparticle systems can modulate immune responses.
• Potential for both beneficial immunomodulation and harmful immunotoxicity exists.

Conclusions:

• Nanoparticle-based allergen delivery systems present a promising avenue for improving AIT.
• Careful consideration of nanoparticle characteristics is crucial for optimizing immunomodulatory effects and minimizing immunotoxicity.
• Further research is needed to fully understand and harness the potential of nanotechnology in allergy treatment.